Skip to main content
SpringerLink
Log in

Stopping follow-up for low-risk subsolid lung nodules cost-effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kong CY, et al. Cost-effectiveness of follow-up for subsolid pulmonary nodules in high-risk patients. Journal of Thoracic Oncology : 11 Mar 2020. Available from: URL: http://doi.org/10.1016/j.jtho.2020.03.001

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stopping follow-up for low-risk subsolid lung nodules cost-effective. PharmacoEcon Outcomes News 850, 31 (2020). https://doi.org/10.1007/s40274-020-6719-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6719-3

Search

Navigation